High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

NCT00662220 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
110
Enrollment
OTHER
Sponsor class

Stopped Due to the arrival of DAAs replacing standard of care for genotype 1 patients the VIRID study had to be terminated.

Conditions

Interventions

Sponsor

Foundation for Liver Research

Collaborators